ÀÇÎѵ¼º½

Our new Center for Molecular Oncology unveils an ambitious new classification system for cancer.

Dr. Liat Shenhav studies human breast milk to understand how it drives early life development.

A reimagined institute aims to develop drugs for conditions where therapeutics are limited.

Advances in AI now enable radiologists to use untapped data from CT scans to enhance patient care.

Dr. Kimmelman discusses the center’s goals for expanding treatments and advancing research.

This work will better inform prevention of age-related diseases, improving the health of older individuals.

An $8 million grant is helping his center use data science to develop effective interventions. 

As people with cancer are living longer, fatigue is becoming a major quality-of-life issue.

Dr. Oren Cahlon aims to minimize the burden of cancer by improving access to world-class care.

Dr. Sylvia Adams’s immunotherapy research provided early access to experimental treatment.